Further studies need to be conducted to determine whether clusterin can be used as an underlying early marker of diabetes-associated MCI; in addition, studies with a larger sample-size should be performed to investigate the association between rs11136000 polymorphism and MCI in T2DM. This evidence concerns the gene CLU and diabetes mellitus.